LOS ANGELES CAPITAL MANAGEMENT LLC
Position in HALO — Halozyme Therapeutics, Inc.
CIK 1177206
LOS ANGELES, CA
Position in HALO
as of Mar 31, 2026
· filed May 8, 2026
Position Value
$44,589,206
-$29,165,940 QoQ
Shares Held
689,915
-37.0% QoQ
Ownership
0.582%
of shares outstanding
% of Portfolio
0.18%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 72.34876760180602.ToString("F0")%
Shared 0.ToString("F0")%
None 27.651232398193983.ToString("F0")%
Common Shares in HALO Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026LOS ANGELES CAPITAL MANAGEMENT LLC holds $690,033,476 across 153 Biotechnology names. HALO ranks #5 (6.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | INCY |
Incyte Corp
|
2,144,847 | $201,872,999 | |
| 2 | EXEL |
Exelixis, Inc.
|
3,102,634 | $133,071,972 | |
| 3 | REGN |
Regeneron Pharmaceuticals, Inc.
|
78,880 | $60,945,843 | |
| 4 | RPRX |
Royalty Pharma plc
|
971,927 | $46,623,338 | |
| 5 | HALO |
Halozyme Therapeutics, Inc.
This page
|
689,915 | $44,589,206 | |
| 6 | CAI |
Caris Life Sciences, Inc.
|
2,289,602 | $40,938,083 | |
| 7 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
88,278 | $29,208,541 | |
| 8 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
64,937 | $28,996,967 |
All Filings in HALO
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $44,589,206 | 689,915 | Shares | Sole | 2026-05-08 | |
| 2025-12-31 | $73,755,146 | 1,095,916 | Shares | Sole | 2026-02-11 | |
| 2025-09-30 | $79,285,967 | 1,081,074 | Shares | Sole | 2025-10-20 | |
| 2025-06-30 | $50,650,313 | 973,670 | Shares | Sole | 2025-08-07 | |
| 2025-03-31 | $5,907,274 | 92,576 | Shares | Sole | 2025-05-05 | |
| 2024-12-31 | $4,421,229 | 92,475 | Shares | Sole | 2025-02-04 | |
| 2024-09-30 | $6,332,461 | 110,630 | Shares | Sole | 2024-11-04 | |
| 2024-06-30 | $6,088,001 | 116,272 | Shares | Sole | 2024-08-05 | |
| 2024-03-31 | $4,922,280 | 121,000 | Shares | Sole | 2024-04-05 | |
| 2023-12-31 | $3,817,376 | 103,284 | Shares | Sole | 2024-02-06 | |
| 2023-09-30 | $3,869,545 | 101,297 | Shares | Sole | 2023-11-06 | |
| 2023-06-30 | $3,299,250 | 91,468 | Shares | Sole | 2023-08-03 | |
| 2023-03-31 | $2,790,925 | 73,080 | Shares | Sole | 2023-05-04 | |
| 2022-12-31 | $8,670,877 | 152,388 | Shares | Sole | 2023-02-06 | |
| 2022-09-30 | $7,162,789 | 181,153 | Shares | Sole | 2022-11-02 | |
| 2022-06-30 | $8,606,972 | 195,613 | Shares | Sole | 2022-08-05 | |
| 2022-03-31 | $7,731,495 | 193,869 | Shares | Sole | 2022-05-06 | |
| 2021-12-31 | $7,795,472 | 193,869 | Shares | Sole | 2022-02-03 | |
| 2021-09-30 | $2,806,472 | 68,989 | Shares | Sole | 2021-11-08 | |
| 2021-06-30 | $2,471,393 | 54,424 | Shares | Sole | 2021-08-05 | |
| 2021-03-31 | $2,895,162 | 69,445 | Shares | Sole | 2021-05-05 | |
| 2020-12-31 | $4,854,461 | 113,661 | Shares | Sole | 2021-03-10 | |
| 2020-09-30 | $2,940,232 | 111,881 | Shares | Sole | 2020-11-02 | |
| 2020-06-30 | $3,846,618 | 143,477 | Shares | Sole | 2020-08-05 | |
| 2020-03-31 | $2,554,777 | 142,011 | Shares | Sole | 2020-05-04 | |
| No filing history on record for this holder in this stock. | ||||||